Trial intelligence / Profile preview

Clonidine versus tranexamic acid for bleeding control in posterior lumbar fusion surgery

IRCT20151012024493N5Phase 3Completed

Sponsor
Shahid Beheshti University of Medical Sciences
Start
Mar 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in Not applicable comparing Clonidine with Tranexamic acid (2 arms). Primary endpoint: Bleeding. Started Mar 2023; status: completed.

02

Drugs

clonidinetranexamic acid
03

Conditions

Not applicable

Beyond the preview

Go deeper on IRCT20151012024493N5.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20151012024493N5.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call